Calypso(R) Medical Technologies Inc. received FDA clearance for the Calypso 4D Localization System. The system utilizes proprietary electromagnetic technology in conjunction with implanted Beacon(R) transponders in the prostate. The product was designed to provide tumor location information during external beam radiation therapy without adding ionizing radiation.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now